If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNE.L Regulatory News (HNE)

  • There is currently no data for HNE

Performance is getting back on track

27 Jul 2023 07:15

RNS Number : 3034H
Henderson Eurotrust PLC
27 July 2023
 

London, UK, 27 July 2023

 

Henderson EuroTrust (HNE): Performance is getting back on track.

Henderson EuroTrust's (HNE's) performance is getting back on track as investors have become more focused on company fundamentals rather than macroeconomic factors, and investors' strong preference for value stocks (translating into style headwinds for HNE between Q121 and Q222) has waned recently. The manager (Jamie Ross) is building on HNE's NAV 10-year record of outperformance versus the Europe ex-UK market (10.5% pa versus 9.1% pa respectively), based on a concentrated portfolio of high-quality growth stocks. European equities are very attractively valued and, coupled with the trust's double-digit discount, this should make HNE worthy of consideration.

 

There is scope for the trust to be afforded a higher valuation now its performance is improving, or if investors become less risk-averse. HNE has one of the widest discounts in its sector despite its performance being above average over the last one, five and 10 years.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first company in-market 17 years ago, Edison has more than 100 employees and covers every economic sector. Headquartered in London, Edison also has offices in New York, Sydney and Wellington.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAXQLFLXDLZBBQ
Date   Source Headline
4th Mar 20243:15 pmRNSNet Asset Value(s)
1st Mar 202412:43 pmRNSNet Asset Value(s)
29th Feb 202411:09 amRNSNet Asset Value(s)
28th Feb 202411:28 amRNSNet Asset Value(s)
27th Feb 202412:17 pmRNSNet Asset Value(s)
26th Feb 20242:40 pmRNSNet Asset Value(s)
23rd Feb 20242:12 pmRNSMonthly Factsheet as at 31 January 2024
23rd Feb 20241:11 pmRNSNet Asset Value(s)
22nd Feb 202411:54 amRNSNet Asset Value(s)
21st Feb 202412:07 pmRNSNet Asset Value(s)
20th Feb 202411:09 amRNSNet Asset Value(s)
19th Feb 20243:01 pmRNSCompliance with Market Abuse Regulation
19th Feb 20242:54 pmRNSNet Asset Value(s)
16th Feb 202411:51 amRNSNet Asset Value(s)
15th Feb 202411:49 amRNSNet Asset Value(s)
14th Feb 202412:23 pmRNSNet Asset Value(s)
13th Feb 202411:43 amRNSNet Asset Value(s)
9th Feb 202411:57 amRNSNet Asset Value(s)
8th Feb 202412:49 pmRNSNet Asset Value(s)
8th Feb 20249:59 amRNSHolding(s) in Company
7th Feb 202411:09 amRNSNet Asset Value(s)
6th Feb 202412:54 pmRNSNet Asset Value(s)
5th Feb 20243:49 pmRNSNet Asset Value(s)
2nd Feb 202412:24 pmRNSNet Asset Value(s)
1st Feb 202411:54 amRNSNet Asset Value(s)
1st Feb 20249:30 amRNSBlock listing Interim Review
31st Jan 202411:45 amRNSNet Asset Value(s)
30th Jan 202412:23 pmRNSNet Asset Value(s)
29th Jan 20242:34 pmRNSNet Asset Value(s)
26th Jan 20242:46 pmRNSNet Asset Value(s)
25th Jan 202411:39 amRNSNet Asset Value(s)
24th Jan 202410:48 amRNSNet Asset Value(s)
23rd Jan 202411:18 amRNSNet Asset Value(s)
22nd Jan 20244:04 pmRNSMonthly Factsheet as at 31 December 2023
22nd Jan 20243:42 pmRNSNet Asset Value(s)
19th Jan 20241:09 pmRNSNet Asset Value(s)
18th Jan 202411:20 amRNSNet Asset Value(s)
17th Jan 202411:59 amRNSNet Asset Value(s)
16th Jan 202412:54 pmRNSNet Asset Value(s)
15th Jan 20242:50 pmRNSNet Asset Value(s)
12th Jan 20242:34 pmRNSNet Asset Value(s)
11th Jan 202412:52 pmRNSNet Asset Value(s)
10th Jan 202412:48 pmRNSNet Asset Value(s)
9th Jan 202411:17 amRNSNet Asset Value(s)
8th Jan 20241:53 pmRNSNet Asset Value(s)
5th Jan 202412:59 pmRNSNet Asset Value(s)
4th Jan 202411:52 amRNSNet Asset Value(s)
3rd Jan 202411:19 amRNSNet Asset Value(s)
29th Dec 202311:28 amRNSNet Asset Value(s)
28th Dec 202311:44 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.